Cargando…
Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report
This paper presents a rare case of an elderly patient treated with erlotinib for disseminated lung adenocarcinoma with poor performance status (Eastern Cooperative Oncology Group performance status [PS]3). This treatment led to a long duration of complete remission according to Response Evaluation C...
Autores principales: | Jovanovic, Dragana, Stevic, Ruza, Velinovic, Marta, Kontic, Milica, Maric, Dragana, Spasic, Jelena, Radosavljevic, Davorin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593392/ https://www.ncbi.nlm.nih.gov/pubmed/28919784 http://dx.doi.org/10.2147/OTT.S131756 |
Ejemplares similares
-
Intestinal Type of Lung Adenocarcinoma in Younger Adults
por: Stojsic, Jelena, et al.
Publicado: (2014) -
Evaluation of Clinical and Genetic Determinants of Treatment OutCome In EGFR Mutation Positive Advanced Lung Adenocarcinoma
por: Jokic, Vera, et al.
Publicado: (2022) -
UNUSUAL CLINICAL COURSE OF NEUROSARCOIDOSIS MANIFESTED WITH ACUTE HYDROCEPHALUS
por: Jovanović, Dragana, et al.
Publicado: (2021) -
Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non‐small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience
por: Savic, Milan, et al.
Publicado: (2017) -
Low-Cost Genetic and Clinical Predictors of Response and Toxicity of
Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung
Cancer
por: Spasic, Jelena, et al.
Publicado: (2022)